Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

The epigenetic factor PCAF regulates vascular inflammation and is essential for intimal hyperplasia development.

de Jong RCM, Ewing MM, de Vries MR, Karper JC, Bastiaansen AJNM, Peters HAB, Baghana F, van den Elsen PJ, Gongora C, Jukema JW, Quax PHA.

PLoS One. 2017 Oct 10;12(10):e0185820. doi: 10.1371/journal.pone.0185820. eCollection 2017.

2.

TLR accessory molecule RP105 (CD180) is involved in post-interventional vascular remodeling and soluble RP105 modulates neointima formation.

Karper JC, Ewing MM, de Vries MR, de Jager SC, Peters EA, de Boer HC, van Zonneveld AJ, Kuiper J, Huizinga EG, Brondijk TH, Jukema JW, Quax PH.

PLoS One. 2013 Jul 2;8(7):e67923. doi: 10.1371/journal.pone.0067923. Print 2013.

3.

Lysine acetyltransferase PCAF is a key regulator of arteriogenesis.

Bastiaansen AJ, Ewing MM, de Boer HC, van der Pouw Kraan TC, de Vries MR, Peters EA, Welten SM, Arens R, Moore SM, Faber JE, Jukema JW, Hamming JF, Nossent AY, Quax PH.

Arterioscler Thromb Vasc Biol. 2013 Aug;33(8):1902-10. doi: 10.1161/ATVBAHA.113.301579. Epub 2013 Jun 20.

4.

Blocking toll-like receptors 7 and 9 reduces postinterventional remodeling via reduced macrophage activation, foam cell formation, and migration.

Karper JC, Ewing MM, Habets KL, de Vries MR, Peters EA, van Oeveren-Rietdijk AM, de Boer HC, Hamming JF, Kuiper J, Kandimalla ER, La Monica N, Jukema JW, Quax PH.

Arterioscler Thromb Vasc Biol. 2012 Aug;32(8):e72-80. doi: 10.1161/ATVBAHA.112.249391. Epub 2012 May 24.

PMID:
22628437
5.

Future potential biomarkers for postinterventional restenosis and accelerated atherosclerosis.

Karper JC, Ewing MM, Jukema JW, Quax PH.

Biomark Med. 2012 Feb;6(1):53-66. doi: 10.2217/bmm.11.107. Review.

PMID:
22296196
6.

Genetic variation in PCAF, a key mediator in epigenetics, is associated with reduced vascular morbidity and mortality: evidence for a new concept from three independent prospective studies.

Pons D, Trompet S, de Craen AJ, Thijssen PE, Quax PH, de Vries MR, Wierda RJ, van den Elsen PJ, Monraats PS, Ewing MM, Heijmans BT, Slagboom PE, Zwinderman AH, Doevendans PA, Tio RA, de Winter RJ, de Maat MP, Iakoubova OA, Sattar N, Shepherd J, Westendorp RG, Jukema JW; PROSPER study group; WOSCOPS study group; GENDER study group.

Heart. 2011 Jan;97(2):143-50. doi: 10.1136/hrt.2010.199927. Epub 2010 Nov 8.

PMID:
21062767
7.

Annexin A5 therapy attenuates vascular inflammation and remodeling and improves endothelial function in mice.

Ewing MM, de Vries MR, Nordzell M, Pettersson K, de Boer HC, van Zonneveld AJ, FrostegÄrd J, Jukema JW, Quax PH.

Arterioscler Thromb Vasc Biol. 2011 Jan;31(1):95-101. doi: 10.1161/ATVBAHA.110.216747. Epub 2010 Oct 14.

PMID:
20947818
8.

Bond failure in clinical practice.

Ewing M.

Aust Orthod J. 2009 Nov;25(2):128-35.

PMID:
20043547
9.

Permanent diversion rates after neoadjuvant therapy and coloanal anastomosis for rectal cancer.

Nelson RS, Boland E, Ewing BM, Blatchford GJ, Ternent C, Shashidharan M, Tran NA, Beaty J, Thorson AG.

Am J Surg. 2009 Dec;198(6):765-70. doi: 10.1016/j.amjsurg.2009.05.024.

PMID:
19969127
10.

Risk of late bleeding following hemorrhoidal banding in patients on antithrombotic prophylaxis.

Nelson RS, Ewing BM, Ternent C, Shashidharan M, Blatchford GJ, Thorson AG.

Am J Surg. 2008 Dec;196(6):994-9; discussion 999. doi: 10.1016/j.amjsurg.2008.07.036.

PMID:
19095121
11.

Clinical outcomes of complicated diverticulitis managed nonoperatively.

Nelson RS, Ewing BM, Wengert TJ, Thorson AG.

Am J Surg. 2008 Dec;196(6):969-72; discussion 973-4. doi: 10.1016/j.amjsurg.2008.07.035.

PMID:
19095117
12.

The utility of intraluminal impedance in patients with gastroesophageal reflux disease-like symptoms but normal endoscopy and 24-hour pH testing.

Kline MM, Ewing M, Simpson N, Laine L.

Clin Gastroenterol Hepatol. 2008 Aug;6(8):880-5; quiz 836. doi: 10.1016/j.cgh.2008.01.016. Epub 2008 Apr 18.

PMID:
18424190

Supplemental Content

Loading ...
Support Center